Stryker announces Annual Meeting of Shareholders
Rhea-AI Summary
Stryker (NYSE:SYK) has scheduled its 2025 Annual Meeting of Shareholders for Thursday, May 8, 2025, at 9:30 a.m. Eastern Time. The meeting will be conducted virtually via the internet.
Shareholders can access the webcast, including audio and slide presentation, through the company's Investor Relations page at www.investorevents.stryker.com. For audio-only participation, attendees can dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker Annual Meeting."
A recording will be available from 10:30 a.m. ET on May 9, 2025, at www.virtualshareholdermeeting.com/SYK2025 until the 2026 proxy statement filing.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, SYK declined 1.37%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows:
Thursday, May 8, 2025 – 9:30 a.m. Eastern Time
The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting as a guest dial (877) 328-2502 (U.S.) or (412) 317-5419 (International) and request the "Stryker Corporation Annual Meeting" when greeted by the operator.
A recording of the annual meeting will also be available from 10:30 a.m., Eastern Time, on Friday, May 9, 2025 at www.virtualshareholdermeeting.com/SYK2025 until the definitive proxy statement for our 2026 Annual Meeting of Shareholders is filed with the United States Securities and Exchange Commission.
About Stryker
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
Contacts
For investor inquiries:
Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Chief Communications Officer at 269-385-2600 or kim.montagnino@stryker.com